The project, funded by the National Institutes of Health’s Bridge2AI program, will continuously gather smartwatch data including heart rate, oxygen and activity levels via Delve Health’s app, combining it with glucose monitoring, according to the Feb. 22 news release.
The study aims to research a diverse group of more than 4,000 people across the U.S. to develop unbiased machine learning models to treat Type 2 diabetes patients.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.